Increase in number of renal failure due to diabetes mellitus, hypertension, and stress, are the key factors influencing industry growth.

According to a new report by Reports and Data, the global Peritoneal Dissolution Market size was valued at USD 3.88 Billion in 2020 and is estimated to exceed USD 5.85 Billion in terms of revenue at a CAGR of 5.3% through 2028. The market growth is driven by expanding global geriatric population base, increasing incidence of ESRD (End-stage renal disease), and the rising acceptance of home hemodissolution and peritoneal dissolution.

Peritoneal dissolution is the filtering of blood along with the elimination of waste fluids by using the peritoneal membrane, the body’s natural filter. The advantages associated with peritoneal dissolution include no use of needles, minimum clinic visits, and provides continuous therapy, which acts more like natural kidneys. This method is mostly performed at home and principally works to remove excess waste products and fluid from the blood.

ESRD, which is generally known as kidney failure is a one of the key factors for growth of the market. Diabetes is the most usual cause of ESRD, whereas high blood pressure is another common cause of ESRD. High blood pressure and diabetes are the most common chronic disease population across the globe. The shortage of kidneys for transplantation owing to stringent regulations in several countries may stimulate industry growth in the coming years. Moreover, a growing aging population that needs long term care requirements, raising awareness about hospital-acquired infections and increased patient preference of advanced kidney treatment will offer lucrative opportunities for the global peritoneal dissolution market growth through 2028.

 Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Market Dynamics:

The pharma and healthcare sector has significantly advanced in the recent years and is expected to register steady revenue growth over the forecast period owing to rapid innovations in medical technology, increasing investments, rising healthcare expenditure and high adoption of advanced products and systems. Factors such as rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and neurological disorders across the globe, rising cases of coronavirus, improving healthcare infrastructure and research facilities, and increasing adoption of remote patient monitoring services and home care settings are expected to fuel global market revenue growth over the forecast period. In addition, increasing number of hospitals and ambulatory care centers worldwide, high demand for personalized medicine, increasing investments in drug discovery and growing investments by public and private sectors are expected to drive global market growth in the coming years.

Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Peritoneal Dissolution Market market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.

Leading companies operating in the market are:

Baxter International, B. Braun, Nipro, Melsungen, Covidien, DaVita Healthcare Partners, Dissolution Clinic, Diversified Specialty Institute Holdings, Fresenius Medical Care, Medical Components, NephroPlus, Huaren Pharmaceutical, Northwest Kidney Centers, NxStage Medical, Satellite Healthcare, Renal Services, Sichuan Kelun Pharmaceutical, U.S. Renal Care, and Sandor, among others.

Get Free Download Summary @

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

Peritoneal Dissolution Market Market Segmentation:

Type Outlook:

Type Outlook (Revenue, USD Million; 2020-2028)

  • Continuous Ambulatory Peritoneal Dissolution (CAPD)
  • Automated Peritoneal Dissolution (APD)

End-user Outlook (Revenue, USD Million; 2020-2028)

  • Home-Based Dissolution
  • Dissolution Center & Hospital Based Dissolution

Product Outlook (Revenue, USD Million; 2020-2028)

  • Peritoneal Dissolution Solution
  • Device
  • Peritoneal Dissolution Set
  • Catheter
  • Others

 Geographic Segment Covered in the Report:

The Peritoneal Dissolution Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Browse Full Report Description with Research Methodology, Table of Content and Infographics @

Further key findings from the report suggest

  • Based on type, the Continuous Ambulatory Peritoneal Dissolution segment is expected to observe a notable growth rate of 5.4% through 2028 on account of its portability, low cost, and lesser machines attachments.
  • Based on end-use, the hospital based dissolution segment accounts for nearly 31.2% of the market share in 2020 and is expected to make significant contributions through 2028. The segmental growth is driven by the availability of unique diagnostic and therapeutic medical technologies that enable quick and accurate diagnosis in these settings.
  • In the regional landscape, Europe accounted for nearly 26.3% of the global peritoneal dissolution market share in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period.
  • In 2020, North America accounted for 35.3% of the global peritoneal dissolution market and is expected to gain major traction through 2028 on account of increasing prevalence of chronic diseases, favorable reimbursement policies, and several initiatives by the government supporting adoption of advanced medical systems in healthcare settings.

 Request customization of the report @

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report. 

Explore More Industry Research by Reports and Data:

Crizotinib Market @

Human Growth Hormone Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports And Data | Web:

Direct Line: +1-212-710-1370


LinkedIn | Twitter | Blogs

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: